Posts

CoQ10, Fibromyalgia, Eating Disorders, and the Importance of Hematological Screening

By
This r ecent research on fibromyalgia and eating disorders has increasingly focused on oxidative stress and mitochondrial dysfunction.  Fibromyalgia, Eating Disorders and Rehabilitation: The Nrf2 Link  https://www.mdpi.com/2076-3921/15/3/364 Because patients with fibromyalgia often show reduced levels of coenzyme Q10 (CoQ10), supplementation is sometimes suggested as a supportive treatment to improve energy metabolism and reduce cellular stress. Similar metabolic disturbances have also been described in individuals with eating disorders. However, many studies addressing eating disorders and fibromyalgia focus mainly on metabolic or psychological factors while overlooking potential underlying hematological conditions . This is a significant gap in clinical evaluation. One example is von Willebrand factor (VWF) abnormalities , which play a central role in blood clotting. Von Willebrand disease and related coagulation disorders are relatively common but often underdiagnosed. ...
Post a Comment
Read more

ACE2-Associated Vascular and Immune Mechanisms Underlying COVID-19 Neurological Injury

By
According to recent research, Receptor-mediated mechanisms underlying neurological complications in COVID-19: from viral entry to neuroinflammation  https://link.springer.com/article/10.1007/s13205-026-04749-4 Neurological problems caused by COVID-19 can occur during the infection or continue afterward as long-term symptoms. Scientists still do not fully understand exactly how these problems develop. However, research from clinical studies, brain imaging, tissue analysis, and molecular biology suggests that the virus usually does not directly infect large parts of the brain. Instead, most neurological damage appears to happen through immune reactions and blood-vessel problems triggered by the virus. The virus mainly enters cells through a receptor called ACE2. Another molecule, neuropilin-1 (NRP1), may help the virus reach areas such as the olfactory system and nearby blood vessels. Other receptors, including CD147 and DPP4, probably do not act as main entry points for the vi...
Post a Comment
Read more

Anticoagulation in Complex Thrombophilia: APS, Factor V Leiden, and von Willebrand Factor Type 2

By
Comparison of Marcumar/Warfarin with Rivaroxaban, Apixaban, Edoxaban, and Dabigatran Etexilate Unfortunately, many patients are not routinely tested for von Willebrand disease, antiphospholipid syndrome (APS), or lupus , which can lead to delayed diagnosis of underlying clotting or bleeding disorders.  Introduction The coexistence of Antiphospholipid Syndrome (APS) , Factor V Leiden mutation , and von Willebrand factor type 2 (vWF type 2) defect represents a highly complex and clinically challenging hemostatic profile. These disorders affect the coagulation system in different and sometimes opposing ways: APS and Factor V Leiden increase the risk of thrombosis, whereas certain forms of von Willebrand disease (particularly type 2 variants) may increase bleeding tendencies. Selecting the most appropriate anticoagulant therapy in such a situation requires careful clinical judgment and individualized risk assessment. Physicians must balance the high risk of recurrent thrombosis a...
Post a Comment
Read more